Skip to main content
Erschienen in: Techniques in Coloproctology 10/2020

28.07.2020 | Multimedia Article

Complete laparoscopic pelvic peritonectomy plus hyperthermic intraperitoneal chemotherapy

verfasst von: A. Arjona-Sánchez, D. Cortés-Guiral, M. Duran-Martínez, P. Villarejo-Campos, J. M. Sánchez-Hidalgo, A. Casado-Adam, L. Rodriguez-Ortiz, A. Romero-Ruiz, B. Rufian-Andujar, E. Espinosa-Redondo, F. Valenzuela-Molina, S. Rufián-Peña, J. Briceño-Delgado

Erschienen in: Techniques in Coloproctology | Ausgabe 10/2020

Einloggen, um Zugang zu erhalten

Abstract

Background

The aim of our study was to present the technique for, and early results of complete laparoscopic pelvic peritonectomy (LPP) plus hyperthermic intraperitoneal chemotherapy (HIPEC).

Methods

We conducted a study on consecutive patients who had LPP for limited peritoneal carcinomatosis (peritoneal carcinomatosis index < 10) from ovarian cancer, colon cancer and benign multicystic mesothelioma, from January 2017 to November 2019 at 2 referral centers in Spain. Perioperative, pathologic, 30-day major morbidity and mortality characteristics were analyzed. The surgical technique is shown in the attached video.

Results

Twelve LPP + HIPEC were performed. Complete cytoreduction was achieved in 100% of the patients, the median duration of the operation was 450 min (range 360–600 min). There were 2 cases (16%) of IIIa morbidity (trocar hernia and pleural effusion), and no mortality. The median length of hospital stay was 5.5 days (range 4–10 days). The median length of follow-up was 10 months (range 2–30 months). There was a recurrence at the splenic hilum in 1 patient which was treated by laparoscopic splenectomy and one nodal recurrence at 13 months while all other patients are alive and free of disease at last follow-up.

Conclusions

This is the first technical video of a minimally invasive approach for complete pelvic peritonectomy plus omentectomy associated with HIPEC. For highly selected patients, this procedure presents a feasible and safe alternative to the maximally invasive approach.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Foster JM, Sleightholm R, Patel A et al (2019) Morbidity and mortality rates following cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy compared with other high-risk surgical oncology procedures. JAMA Netw Open 2(1):e186847CrossRef Foster JM, Sleightholm R, Patel A et al (2019) Morbidity and mortality rates following cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy compared with other high-risk surgical oncology procedures. JAMA Netw Open 2(1):e186847CrossRef
2.
Zurück zum Zitat Sugarbaker PH (2013) Cytoreductive surgery & perioperative chemotherapy for peritoneal surface malignancy: textbook and video atlas. PSOGI 1:1–22 Sugarbaker PH (2013) Cytoreductive surgery & perioperative chemotherapy for peritoneal surface malignancy: textbook and video atlas. PSOGI 1:1–22
3.
Zurück zum Zitat Chua TC, Yan TD, Saxena A, Morris DL (2009) Should the treatment of peritoneal carcinomatosis by cytoreductive surgery andhyperthermic intraperitoneal chemotherapy still be regarded as a highly morbid procedure?: a systematic review of morbidity and mortality. Ann Surg 249:900–907CrossRef Chua TC, Yan TD, Saxena A, Morris DL (2009) Should the treatment of peritoneal carcinomatosis by cytoreductive surgery andhyperthermic intraperitoneal chemotherapy still be regarded as a highly morbid procedure?: a systematic review of morbidity and mortality. Ann Surg 249:900–907CrossRef
4.
Zurück zum Zitat Esquivel J, Averbach A, Chua TC (2011) Laparoscopic cytoreductivesurgery and hyperthermic intraperitoneal chemotherapyin patients with limited peritoneal surface malignancies: feasibility, morbidity and outcome in an early experience. Ann Surg 253:764–768CrossRef Esquivel J, Averbach A, Chua TC (2011) Laparoscopic cytoreductivesurgery and hyperthermic intraperitoneal chemotherapyin patients with limited peritoneal surface malignancies: feasibility, morbidity and outcome in an early experience. Ann Surg 253:764–768CrossRef
5.
Zurück zum Zitat Passot G, Bakrin N, Isaac S, Decullier E, Gilly FN, Glehen O, Cotte E (2013) Postoperative outcomes of laparoscopic vs open cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for treatment of peritoneal surface malignancies. Eur J Surg Oncol 40:957–962CrossRef Passot G, Bakrin N, Isaac S, Decullier E, Gilly FN, Glehen O, Cotte E (2013) Postoperative outcomes of laparoscopic vs open cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for treatment of peritoneal surface malignancies. Eur J Surg Oncol 40:957–962CrossRef
6.
Zurück zum Zitat Arjona-Sanchez A, Esquivel J, Glehen O et al (2019) A minimally invasive approach for peritonectomy procedures and hyperthermic intraperitoneal chemotherapy (HIPEC) in limited peritoneal carcinomatosis: The American Society of Peritoneal Surface Malignancies (ASPSM) multi-institution analysis. Surg Endosc 33(3):854–860CrossRef Arjona-Sanchez A, Esquivel J, Glehen O et al (2019) A minimally invasive approach for peritonectomy procedures and hyperthermic intraperitoneal chemotherapy (HIPEC) in limited peritoneal carcinomatosis: The American Society of Peritoneal Surface Malignancies (ASPSM) multi-institution analysis. Surg Endosc 33(3):854–860CrossRef
7.
Zurück zum Zitat Arjona-Sanchez A, Rufian-Peña S, Sanchez-Hidalgo JM, Casado-Adam A, Cosano-Alvarez A, Briceño-Delgado J (2018) Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy (HIPEC) by minimally invasive approach, an initial experience. World J Surg 42(10):3120–3124CrossRef Arjona-Sanchez A, Rufian-Peña S, Sanchez-Hidalgo JM, Casado-Adam A, Cosano-Alvarez A, Briceño-Delgado J (2018) Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy (HIPEC) by minimally invasive approach, an initial experience. World J Surg 42(10):3120–3124CrossRef
8.
Zurück zum Zitat Arjona-Sanchez A, Durán M, Sanchez Hidalgo JM, Rufian Peña S (2019) Peritoneal carcinomatosis from ovarian carcinoma treated by interval laparoscopic complete cytoreduction and HIPEC with extraction through natural orifice. Surg Oncol 31:14–15CrossRef Arjona-Sanchez A, Durán M, Sanchez Hidalgo JM, Rufian Peña S (2019) Peritoneal carcinomatosis from ovarian carcinoma treated by interval laparoscopic complete cytoreduction and HIPEC with extraction through natural orifice. Surg Oncol 31:14–15CrossRef
9.
Zurück zum Zitat Gallotta V, Ghezzi F, Vizza E, Fagotti A, Ceccaroni M, Fanfani F, Chiantera V, Ercoli A, Rossitto C, Conte C, Uccella S, Corrado G, Scambia G, Ferrandina G (2016) Laparoscopic management of ovarian cancer patients with localized carcinomatosis and lymph node metastases: results of a retrospective multi-institutional series. J Min Invasive Gynecol 23(4):590–596CrossRef Gallotta V, Ghezzi F, Vizza E, Fagotti A, Ceccaroni M, Fanfani F, Chiantera V, Ercoli A, Rossitto C, Conte C, Uccella S, Corrado G, Scambia G, Ferrandina G (2016) Laparoscopic management of ovarian cancer patients with localized carcinomatosis and lymph node metastases: results of a retrospective multi-institutional series. J Min Invasive Gynecol 23(4):590–596CrossRef
10.
Zurück zum Zitat Harter P, Sehouli J, Lorusso D et al (2019) A randomized trial of lymphadenectomy in patients with advanced ovarian neoplasms. N Engl J Med 380:822–832CrossRef Harter P, Sehouli J, Lorusso D et al (2019) A randomized trial of lymphadenectomy in patients with advanced ovarian neoplasms. N Engl J Med 380:822–832CrossRef
11.
Zurück zum Zitat Sánchez-Hidalgo JM, Rodríguez-Ortiz L, Arjona-Sánchez A et al (2019) Colorectal peritoneal metastases: optimal management review. World J Gastroenterol 25(27):3484–3502CrossRef Sánchez-Hidalgo JM, Rodríguez-Ortiz L, Arjona-Sánchez A et al (2019) Colorectal peritoneal metastases: optimal management review. World J Gastroenterol 25(27):3484–3502CrossRef
12.
Zurück zum Zitat Quenet F, Elias D, Roca L et al (2018) A UNICANCER phase III trial of hyperthermic intra-peritoneal chemotherapy (HIPEC) for colorectal peritoneal carcinomatosis (PC): PRODIGE 7. J Clin Oncol 36:3503CrossRef Quenet F, Elias D, Roca L et al (2018) A UNICANCER phase III trial of hyperthermic intra-peritoneal chemotherapy (HIPEC) for colorectal peritoneal carcinomatosis (PC): PRODIGE 7. J Clin Oncol 36:3503CrossRef
13.
Zurück zum Zitat Prada-Villaverde A, Esquivel J, Lowy AM et al (2014) The American Society of Peritoneal Surface Malignancies Evaluation of HIPEC with mitomycin C versus oxaliplatin in 539 patients with colon cancer undergoing a complete cytoreductive surgery. J Surg Oncol 110(7):779–785CrossRef Prada-Villaverde A, Esquivel J, Lowy AM et al (2014) The American Society of Peritoneal Surface Malignancies Evaluation of HIPEC with mitomycin C versus oxaliplatin in 539 patients with colon cancer undergoing a complete cytoreductive surgery. J Surg Oncol 110(7):779–785CrossRef
Metadaten
Titel
Complete laparoscopic pelvic peritonectomy plus hyperthermic intraperitoneal chemotherapy
verfasst von
A. Arjona-Sánchez
D. Cortés-Guiral
M. Duran-Martínez
P. Villarejo-Campos
J. M. Sánchez-Hidalgo
A. Casado-Adam
L. Rodriguez-Ortiz
A. Romero-Ruiz
B. Rufian-Andujar
E. Espinosa-Redondo
F. Valenzuela-Molina
S. Rufián-Peña
J. Briceño-Delgado
Publikationsdatum
28.07.2020
Verlag
Springer International Publishing
Erschienen in
Techniques in Coloproctology / Ausgabe 10/2020
Print ISSN: 1123-6337
Elektronische ISSN: 1128-045X
DOI
https://doi.org/10.1007/s10151-020-02277-8

Weitere Artikel der Ausgabe 10/2020

Techniques in Coloproctology 10/2020 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.